SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-093198
Filing Date
2024-04-11
Accepted
2024-04-11 16:06:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d815184d424b5.htm 424B5 483039
2 GRAPHIC g815184g00x01.jpg GRAPHIC 59902
  Complete submission text file 0001193125-24-093198.txt   566820
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 424B5 | Act: 33 | File No.: 333-258448 | Film No.: 24838550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)